Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Williams

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Immunity|November 5, 2014
miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammationRuozhen Hu, Dominique A Kagele, Thomas B Huffaker, et al.
The Journal of Clinical Investigation|June 19, 2003
Heterologous immunity provides a potent barrier to transplantation toleranceAndrew B Adams, Matthew A Williams, Thomas R Jones, et al.
The Journal of Biological Chemistry|September 16, 2017
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockadeThomas B Huffaker, Soh-Hyun Lee, William W Tang, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
Shp-1 regulates the activity of low-affinity T cells specific to endogenous self-antigen during melanoma tumor growth and drives resistance to immune checkpoint inhibitionJoseph G Matous, Jeremy P Snook, Nico A Contreras, et al.
Oncotarget|July 9, 2016
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanomaAbhijit Ray, Matthew A Williams, Stephanie M Meek, et al.
Nature Communications|August 4, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapyYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Immunity|November 5, 2014
miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammationRuozhen Hu, Dominique A Kagele, Thomas B Huffaker, et al.
The Journal of Clinical Investigation|June 19, 2003
Heterologous immunity provides a potent barrier to transplantation toleranceAndrew B Adams, Matthew A Williams, Thomas R Jones, et al.
The Journal of Biological Chemistry|September 16, 2017
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockadeThomas B Huffaker, Soh-Hyun Lee, William W Tang, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
Shp-1 regulates the activity of low-affinity T cells specific to endogenous self-antigen during melanoma tumor growth and drives resistance to immune checkpoint inhibitionJoseph G Matous, Jeremy P Snook, Nico A Contreras, et al.
Oncotarget|July 9, 2016
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanomaAbhijit Ray, Matthew A Williams, Stephanie M Meek, et al.
Nature Communications|August 4, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapyYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Pageof 6